154 related articles for article (PubMed ID: 23743194)
21. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
22. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
Lee J
Arch Pharm Res; 2010 Sep; 33(9):1401-9. PubMed ID: 20945139
[TBL] [Abstract][Full Text] [Related]
23. Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells.
Chang G; Chen L; Lin HM; Lin Y; Maranchie JK
J Exp Ther Oncol; 2012; 10(1):9-18. PubMed ID: 22946340
[TBL] [Abstract][Full Text] [Related]
24. Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
Ryu H; Jin H; Ho JN; Bae J; Lee E; Lee SE; Lee S
Biol Pharm Bull; 2019; 42(1):66-72. PubMed ID: 30606990
[TBL] [Abstract][Full Text] [Related]
25. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
26. Probenecid is a chemosensitizer in cancer cell lines.
Campos-Arroyo D; MartÃnez-Lazcano JC; Melendez-Zajgla J
Cancer Chemother Pharmacol; 2012 Feb; 69(2):495-504. PubMed ID: 21861129
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
28. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
29. Extracellular release of annexin II from pancreatic cancer cells and resistance to anticancer drug-induced apoptosis by supplementation of recombinant annexin II.
Sato T; Kita K; Sugaya S; Suzuki T; Suzuki N
Pancreas; 2012 Nov; 41(8):1247-54. PubMed ID: 22750966
[TBL] [Abstract][Full Text] [Related]
30. Synergistic induction of apoptosis by methylseleninic acid and cisplatin, the role of ROS-ERK/AKT-p53 pathway.
Zhang Y; Zheng S; Zheng JS; Wong KH; Huang Z; Ngai SM; Zheng W; Wong YS; Chen T
Mol Pharm; 2014 Apr; 11(4):1282-93. PubMed ID: 24555485
[TBL] [Abstract][Full Text] [Related]
31. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways.
Hwang JT; Ha J; Park OJ
Biochem Biophys Res Commun; 2005 Jul; 332(2):433-40. PubMed ID: 15896711
[TBL] [Abstract][Full Text] [Related]
32. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
33. LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.
Li F; Yang W; Guo D; Hu Z; Xu H; Ye Z
Oncol Rep; 2011 Jun; 25(6):1629-37. PubMed ID: 21431282
[TBL] [Abstract][Full Text] [Related]
34. Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis.
Zhang Y; Adachi M; Kawamura R; Imai K
Cell Death Differ; 2006 Jan; 13(1):129-40. PubMed ID: 15947789
[TBL] [Abstract][Full Text] [Related]
35. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
36. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells.
Lee EL; Shimizu T; Ise T; Numata T; Kohno K; Okada Y
J Cell Physiol; 2007 May; 211(2):513-21. PubMed ID: 17186499
[TBL] [Abstract][Full Text] [Related]
37. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiyama H
Cancer Res; 2007 Feb; 67(3):1212-20. PubMed ID: 17283157
[TBL] [Abstract][Full Text] [Related]
38. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
[TBL] [Abstract][Full Text] [Related]
40. Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
Pattarawat P; Hong T; Wallace S; Hu Y; Donnell R; Wang TH; Tsai CL; Wang J; Wang HR
Br J Cancer; 2020 Jul; 123(2):226-239. PubMed ID: 32390005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
